SelectQuote, Bain Capital
TOKYO (Reuters) - U.S. private equity firm Bain Capital said it may withdraw its tender offer proposal for Japanese IT firm ...
Private equity firm Bain Capital (BCSF) is paying $3.4 billion to buy a 350-year-old Japanese drugs group fighting diabetes ...
In a statement, Bain said that it is 'carefully considering' its future policy, including 'the option of withdrawing' its ...
The Japanese chemical company has agreed to sell its pharmaceutical business to Bain Capital for more than $3 billion, in a ...
Bain Capital is considering withdrawing its tender offer for Japanese IT firm Fuji Soft after rival U.S. private equity giant ...
The carve-out acquisition will allow Bain to capitalize on the “promising signs for growth” in the Japanese life sciences ...
Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter ...
Bain Capital Private Equity has proposed to acquire the remaining shares of surgical facility operator Surgery Partners it ...
Keith Largay joins Bain Capital from JLL, where he spent 14 years and most recently served as co-head of its Chicago office.
Kestra Medical Technologies Ltd. has filed for an initial public offering, showing revenue growth that nearly tripled.Most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results